Robert Johnson
Login to view DISC.Robert Johnson is the CEO of Kesmalea Therapeutics, focusing on developing small molecule protein degraders. He is a seasoned biotech executive with a track record of founding and leading companies, including Adrestia Therapeutics, which he sold to Insmed. Colleagues describe him as professional, creative, tenacious, and an astute negotiator.
Outside of work, Robert is a dedicated runner and fundraiser. He recently completed the London Marathon to raise money and awareness for the Ataxia Telangiectasia Society, a charity supporting children and families affected by a rare and complex genetic condition that causes severe disability.
He ran his first marathon to raise funds for research into Ataxia Telangiectasia, a rare disease his former company was working to treat.
Read the full overview →How Robert shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Robert cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.